PTCB / PTCE guideContent domains

PTCB Patient Safety & Quality Assurance: What to Study

Domain 3 is 23.75% of the 2026 PTCE. Study high-alert and LASA drugs, error prevention, pharmacist intervention, event reporting, prescription errors, and infection prevention.

Short answer

PTCE Domain 3, Patient Safety and Quality Assurance, is 23.75% of the outline effective January 6, 2026. It covers high-alert and look-alike/sound-alike medications, error-prevention methods, pharmacist intervention issues such as DUR and ADE and OTC concerns, event reporting including MedWatch and VAERS and RCA and CQI, types of prescription errors, and infection-prevention procedures including PPE and cleaning standards. Several knowledge areas are calculation-based. The domain is about catching and escalating risk, not about diagnosing patients.

Safety is a domain, not a motivational poster

Patient Safety and Quality Assurance is 23.75% of the current PTCE. That is larger than Federal Requirements. Practice safety-and-escalation questions in the Passy PTCB prep app the way the outline writes them: high-alert names, error-prone expressions, and who gets the next action.

Current knowledge areas include:

  • High-alert and look-alike/sound-alike medications
  • Error-prevention strategies (for example Tall Man lettering, trailing-zero avoidance, barcode checks)
  • Issues that require pharmacist intervention, including drug utilization review, adverse drug events, and OTC counseling handoff (some calculation-based)
  • Event reporting procedures such as MedWatch, VAERS, root-cause analysis, and continuous quality improvement
  • Types of prescription errors (some calculation-based)
  • Infection prevention, PPE, and cleaning of trays, counters, and equipment

LASA and high-alert are not the same list

Look-alike / sound-alike pairs confuse names (hydrALAZINE versus hydrOXYzine). High-alert medications cause disproportionate harm when used in error (for example anticoagulants, concentrated electrolytes, insulin as a class of risk). A drug can be both. Studying only “top 200” names without those safety layers leaves Domain 3 thin.

Tall Man lettering is an error-prevention method the outline expects you to recognize. Trailing zeros on doses (“5.0 mg”) and missing leading zeros (“.5 mg”) are prescription-error patterns. Stop and get the pharmacist. Do not “fix” a dangerous expression by guessing. Drill LASA pairs and error-prone expressions in the Passy PTCE prep app until the stop-and-ask reflex is automatic.

PTCB Medications is class and indication knowledge. Patient Safety is about what you do when the name, the decimal, or the product choice is unsafe.

Reporting and infection control are operational

MedWatch and VAERS are reporting pathways, not optional paperwork trivia. Root-cause analysis and CQI are how pharmacies learn from events. You do not need to invent a hospital’s entire policy. You do need to know that events get documented and escalated rather than hidden.

Infection prevention is concrete: hand hygiene, PPE when required, and cleaning counting trays between products that can cross-contaminate (including penicillin-containing products in many workflows). That is technician work the outline still names. If reporting or infection-control items are where you slip, target reporting and infection-control misses in the Passy PTCB prep app.

Prescription-error types can include wrong drug, wrong strength, wrong patient, wrong directions, and quantity or days-supply mismatches. Some of those are calculation-based. PTCB pharmacy math is the setup page. Order Entry is the NDC and Sig page.

Federal Requirements covers recalls and DSCSA quarantine, which sit next to this domain but are not the same thing. LASA pairs and trailing zeros are not optional extras on a 23.75% domain. After each error-type drill, mix safety questions with medications and order entry in the Passy prep app for the PTCB exam so Domain 3 is not only a LASA matching game.

Trust the source

Official sources

Exam policies can change. Use these primary sources for the most current details.